Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555905 · ClinicalTrials.gov registry record · NA
Respiratory Muscle Strength in Patients With NMD
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01555905 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 17 participants.
The verdict
NCT01555905, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if inspiratory muscle strength training (IMST) will impact maximal inspiratory pressure and pulmonary function in patients with neuromuscular disease.
Interventions
- DEVICE Threshold PEP or IMT device Phillips-Respironics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2011-04 |
| Est. Completion | 2022-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01555905
The ClinicalTrials.gov registry entry for NCT01555905 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Threshold PEP or IMT device Phillips-Respironics is the first listed.
NCT01555905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01555905 about?
NCT01555905 is a clinical study titled "Respiratory Muscle Strength in Patients With NMD". The purpose of this study is to determine if inspiratory muscle strength training (IMST) will impact maximal inspiratory pressure and pulmonary function in patients with neuromuscular disease.
What is the current status of trial NCT01555905?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2011-04. Estimated completion is 2022-03.
What interventions are being tested in trial NCT01555905?
The interventions under investigation include: Threshold PEP or IMT device Phillips-Respironics (DEVICE).
Who is sponsoring clinical trial NCT01555905?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.